What does Dr CHIERCHIA -Cardiologie do?

Dr CHIERCHIA -Cardiologie is a specialist medical practice in Ukkel. Private Limited, started on 3 March 2014, 1 establishment.

What is the address of Dr CHIERCHIA -Cardiologie?

The registered office of Dr CHIERCHIA -Cardiologie is located at Coghenlaan 103, 1180 Ukkel.

Is Dr CHIERCHIA -Cardiologie still active?

Yes. According to the CBE (2 November 2026) Dr CHIERCHIA -Cardiologie is active, legal situation “Normale toestand”, started on 3 March 2014.

Is Dr CHIERCHIA -Cardiologie registered on Peppol?

Yes, Dr CHIERCHIA -Cardiologie is registered on the Peppol network with ID 0208:0547605184.

What is the enterprise number of Dr CHIERCHIA -Cardiologie?

The enterprise number of Dr CHIERCHIA -Cardiologie is BE0547605184.

When was Dr CHIERCHIA -Cardiologie founded?

Dr CHIERCHIA -Cardiologie was founded on 3 March 2014.

Who are the directors of Dr CHIERCHIA -Cardiologie?

According to the 2025 annual accounts, the directors of Dr CHIERCHIA -Cardiologie are: Gian Battista Chierchia.

Is Dr CHIERCHIA -Cardiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 March 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr CHIERCHIA -Cardiologie make in 2025?

Dr CHIERCHIA -Cardiologie posted a profit after taxes of € 642,926 in financial year 2025.

What is the revenue of Dr CHIERCHIA -Cardiologie?

As a small company, Dr CHIERCHIA -Cardiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 872,674.

Dr CHIERCHIA -Cardiologie (Private Limited) - Ukkel

Dossier Dr CHIERCHIA -Cardiologie, printed on 2 November 2026 from databakkes.be/en/0547605184/dr-chierchia-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr CHIERCHIA -Cardiologie from Ukkel, company number BE0547605184, closed financial year 2025 with a result of € 642,926 after tax. For that financial year Dr CHIERCHIA -Cardiologie recorded a gross margin of € 872,674 and equity of € 211,845. Compared with financial year 2024, the result moved from € 495,318 to € 642,926. Profitable, and profit is growing. The buffer shrank hard: equity is 59 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Shrank hard

€ 211,845

▼ 59% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 642,926

▲ 30% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 179,855

▼ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 945,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

€ 92,262

▲ 10% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 3,577

▼ 46% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 23,811

▲ 169% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 668,720 Gross margin 2022: € 668,720 First fiscal year in the series	€ 722,831 Gross margin 2023: € 722,831 ▲ 8% vs 2022 (€ 668,720) Favourable step	€ 679,455 Gross margin 2024: € 679,455 ▼ 6% vs 2023 (€ 722,831) Unfavourable step	€ 872,674 Gross margin 2025: € 872,674 ▲ 28% vs 2024 (€ 679,455) Favourable step	▲ 28%
Profit after taxes	€ 490,306 Profit after taxes 2022: € 490,306 First fiscal year in the series	€ 560,178 Profit after taxes 2023: € 560,178 ▲ 14% vs 2022 (€ 490,306) Favourable step	€ 495,318 Profit after taxes 2024: € 495,318 ▼ 12% vs 2023 (€ 560,178) Unfavourable step	€ 642,926 Profit after taxes 2025: € 642,926 ▲ 30% vs 2024 (€ 495,318) Favourable step	▲ 30%
Equity	€ 511,597 Equity 2022: € 511,597 First fiscal year in the series	€ 581,776 Equity 2023: € 581,776 ▲ 14% vs 2022 (€ 511,597) Favourable step	€ 513,918 Equity 2024: € 513,918 ▼ 12% vs 2023 (€ 581,776) Unfavourable step	€ 211,845 Equity 2025: € 211,845 ▼ 59% vs 2024 (€ 513,918) Unfavourable step	▼ 59%
Total debts	€ 118,844 Total debts 2022: € 118,844 First fiscal year in the series	€ 130,554 Total debts 2023: € 130,554 ▲ 10% vs 2022 (€ 118,844) Unfavourable step	€ 109,283 Total debts 2024: € 109,283 ▼ 16% vs 2023 (€ 130,554) Favourable step	€ 127,326 Total debts 2025: € 127,326 ▲ 17% vs 2024 (€ 109,283) Unfavourable step	▲ 17%
Cash	€ 511,133 Cash 2022: € 511,133 First fiscal year in the series	€ 552,344 Cash 2023: € 552,344 ▲ 8% vs 2022 (€ 511,133) Favourable step	€ 442,133 Cash 2024: € 442,133 ▼ 20% vs 2023 (€ 552,344) Unfavourable step	€ 179,855 Cash 2025: € 179,855 ▼ 59% vs 2024 (€ 442,133) Unfavourable step	▼ 59%
Retained profit	€ 492,997 Retained profit 2022: € 492,997 First fiscal year in the series	€ 563,176 Retained profit 2023: € 563,176 ▲ 14% vs 2022 (€ 492,997) Favourable step	€ 495,318 Retained profit 2024: € 495,318 ▼ 12% vs 2023 (€ 563,176) Unfavourable step	€ 193,245 Retained profit 2025: € 193,245 ▼ 61% vs 2024 (€ 495,318) Unfavourable step	▼ 61%
Dividend	€ 415,000 Dividend 2022: € 415,000 First fiscal year in the series	€ 490,000 Dividend 2023: € 490,000 ▲ 18% vs 2022 (€ 415,000) Unchanged	€ 563,176 Dividend 2024: € 563,176 ▲ 15% vs 2023 (€ 490,000) Unchanged	€ 945,000 Dividend 2025: € 945,000 ▲ 68% vs 2024 (€ 563,176) Unchanged	▲ 68%
Bank debt	€ 62,729 Bank debt 2022: € 62,729 First fiscal year in the series	€ 83,991 Bank debt 2023: € 83,991 ▲ 34% vs 2022 (€ 62,729) Unfavourable step	€ 83,996 Bank debt 2024: € 83,996 Unchanged (€ 83,991) Unfavourable step	€ 92,262 Bank debt 2025: € 92,262 ▲ 10% vs 2024 (€ 83,996) Unfavourable step	▲ 10%
Balance sheet total	€ 630,441 Balance sheet total 2022: € 630,441 First fiscal year in the series	€ 712,329 Balance sheet total 2023: € 712,329 ▲ 13% vs 2022 (€ 630,441) Unchanged	€ 623,201 Balance sheet total 2024: € 623,201 ▼ 13% vs 2023 (€ 712,329) Unchanged	€ 339,170 Balance sheet total 2025: € 339,170 ▼ 46% vs 2024 (€ 623,201) Unchanged	▼ 46%

Key figures of Dr CHIERCHIA -Cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr CHIERCHIA -Cardiologie?

What happened at Dr CHIERCHIA -Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 642,926 (▲ 30% vs 2024). Source: NBB ↗
Mar 3, 2014 Start of the company according to the CBE. KBO
Feb 25, 2014 New establishment in Ukkel. KBO
2014 Gian Battista Chierchia became a director. NBB

In short

From € 490,306 profit in 2022 to € 642,926 profit in 2025.

Paid € 703,003 in corporate taxes since 2022.

Best year ever: 2025, with € 642,926 profit.

Paid out € 2.4 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Gian Battista Chierchia

Dr CHIERCHIA -Cardiologie

Behind Dr CHIERCHIA -Cardiologie is Gian Battista Chierchia.

Directors

According to the 2025 annual accounts

Gian Battista Chierchia

Director

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Coghenlaan 103

1180 Ukkel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0547.605.184
VAT number: BE 0547.605.184
Registered office: Coghenlaan 103, 1180 Ukkel
Names & denominations: Dr CHIERCHIA -Cardiologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 March 2014
Peppol: Active · Active since 6 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗